We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.14 | 6.91% | 2.165 | 2.05 | 2.28 | 2.29 | 1.995 | 2.00 | 4,381,830 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/4/2020 21:17 | Trick..expectation alone will increase the price.. the journey to phase111 results is worth 50p alone..not to mention the diversity of new developments of other avenues | halfbutt | |
20/4/2020 21:00 | I'd like to buy back in here but my head says no and that's good enough for me. I just can't bring myself to trust Tim. | tricky red | |
20/4/2020 16:00 | You may be right...but nothing goes up in a straight line.....always buy the dips or in the case of AIM stocks the characteristic massive pullbacks | kop202 | |
20/4/2020 15:41 | That's excellent ramping....tantalisi | kop202 | |
20/4/2020 15:34 | Dont buy then kop......plenty are... 50p will happen ... | halfbutt | |
20/4/2020 15:30 | MM's working hard to tempt investors......once bitten twice shy and all that.Tim will have to bare his buttocks in Mark's and Sparks window before I'll be tempted back....oh or Lupuzer obtains FDA approval | kop202 | |
18/4/2020 19:09 | Nobby, Please see “inv” historic posts. He is just BS. Ignore. | idontflykathyy | |
18/4/2020 10:10 | Which is? Do you have inside information? | nobbygnome | |
17/4/2020 14:26 | excellent news coming shortly | inv | |
16/4/2020 18:11 | Another strong day on lower volume... breaking out and having an increased support limit... might try to challenge 19p soon hopefully...now with 20% gain but holding for the big number 50 | halfbutt | |
15/4/2020 15:44 | Avion is a minnow..... | bendaddy | |
15/4/2020 14:20 | Triple support at 14p ?? | halfbutt | |
15/4/2020 13:01 | Dipped my toe in here ... looking good imvho | sophisticatedtrader | |
15/4/2020 12:30 | O/T - N4P Mcap: £6m N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec(R), a novel delivery system for cancer treatments and vaccines, announces that it will be undertaking a proof of concept research project using a Covid-19 DNA plasmid for the purpose of demonstrating the ability of Nuvec(R) to be used as a delivery system by potential collaboration partners developing Covid-19 DNA or RNA vaccines. | soldi | |
15/4/2020 11:47 | Massive volume and buys keeps on coming, 20p could be today at this rate or even more | ntbb | |
15/4/2020 09:20 | When you have big brother like avion partnering with you I'm sure others will follow | ntbb | |
15/4/2020 09:05 | Might be Tim explaining the array of other drugs in development and not just lupuzor..his interview was detailing how much other interest and activity in the pipeline.. hopefully people investing on future price rise which is always the way .never the present | halfbutt | |
15/4/2020 09:05 | 2 days of high volume and price rising I think news soon | ntbb | |
15/4/2020 08:53 | Wonder if this rise is due to the fda meeting | ntbb | |
14/4/2020 13:44 | Any drug in the immune response field is ticking up, eg SAR today. (pro-inflammatory responses in autoimmune diseases) | andrbea | |
14/4/2020 12:00 | All we need now is to get an RNS with something Covid-19 related. LOL! | greenrichard | |
14/4/2020 11:17 | We're going up.... hxxps://proactiveinv | tarny | |
14/4/2020 08:01 | Hatetrader1.....is a scammer. Same link on multiple boards. Do not click on link. Joint ADVFN on the 10.4.20 | flavio_monteiro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions